Table.
Baseline demographic data characteristics of study participants. Footnote: Values are mean ± SD unless otherwise indicated.
| Baseline maternal characteristics | Rescue AS (n=44) | Placebo (n=41) | p |
|---|---|---|---|
| Age, years | 26.9 ± 7.5 | 28.6 ± 6.4 | ns |
| Gravida, n | 3.0 ± 2.1 | 3.0 ± 1.8 | ns |
| Parida, n | 1.2 ± 1.4 | 1.4 ± 1.3 | ns |
| Non-white race, n (%) | 14 (32) | 14 (34) | ns |
| ROM >24hrs, n (%) | 9 (20) | 6 (15) | ns |
| Vaginal delivery, n (%) | 20 (45) | 17 (41) | ns |
| Smoking per history, n (%) | 11 (25) | 2 (5) | < 0.05 |
| Chorioamnionitis, n (%) | 0 (0) | 2 (5) | ns |
| Twin Gestation, n (%) | 12 (27) | 16 (39) | ns |
| Time between 1st AS and study drug, days | 22.8 ± 9.3 | 22.9 ± 10.7 | ns |
| Time between study drug and delivery, days | 16.3 ± 18.6 | 14.6 ± 15.8 | ns |
| Baseline infant characteristics | Rescue AS (n=56) | Placebo (n=56) | |
|---|---|---|---|
| GA at birth, weeks | 31.9 ± 3.3 | 32.3 ± 2.9 | ns |
| Birth weight, g | 1806 ± 778 | 1830 ± 657 | ns |
| Age at first PFTs, hours | 29.5 ± 22.8 | 28.0 ± 21.5 | ns |
| Intubated at first PFTs, n (%) | 15 (27) | 18 (32) | ns |
| GA at last PFTs, weeks | 36.4 ± 2.0 | 36.2 ± 2.5 | ns |